Evaluation of apremilast in chronic pruritus of unknown origin: A proof-of-concept, phase 2a, open-label, single-arm clinical trial.

ABSTRACT:

SUBMITTER: Clark M 

PROVIDER: S-EPMC7178825 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature